Pharmacyclics, Inc.
(NASDAQ : PCYC)

( )
PCYC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading PCYC News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.11%123.560.7%$679.19m
PFEPfizer Inc.
0.30%33.861.1%$617.69m
MRKMerck & Co., Inc.
0.67%62.720.6%$491.44m
BMYBristol-Myers Squibb Company
-0.37%53.741.4%$449.24m
LLYEli Lilly and Company
-0.27%80.980.9%$338.49m
ABBVAbbVie, Inc.
-0.06%65.062.0%$311.73m
NVSNovartis AG Sponsored ADR
0.17%76.370.2%$156.66m
GSKGlaxoSmithKline plc Sponsored ADR
-1.91%40.690.2%$124.19m
AZNAstraZeneca PLC Sponsored ADR
0.30%30.581.3%$104.63m
NVONovo Nordisk A/S Sponsored ADR Class B
0.81%37.380.1%$86.04m
SNYSanofi Sponsored ADR
0.09%46.440.2%$67.28m
AKTXAkari Therapeutics Plc Sponsored ADR
7.93%16.460.1%$32.99m
LCILannett Company, Inc.
5.56%26.6039.1%$20.02m
SCMPSucampo Pharmaceuticals, Inc. Class A
2.06%9.9015.7%$6.61m
EPIXESSA Pharma Inc
-6.62%2.050.0%$0.01m

Company Profile

Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has three product candidates in clinical development and several preclinical molecules in lead optimization. The company was founded in 1991 and is headquartered in Sunnyvale, CA.